Operator: Good afternoon, ladies and gentlemen. Thank you for attending today s Bio-Rad Fourth Quarter and Full Year 2022 Earnings Results Conference Call.
HERCULES, Calif. (BUSINESS WIRE) Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WS.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding